Affimed (AFMD) EBITDA US GAAP (year values)

2021 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EBITDA, ? -64 006 000 -64 006 000 -86 637 000 -86 637 000 -103 810 000   -69 820 000  
Changes by years, y/y, % +87% 0% +35% 0% +20%     +40.6%

Affimed. EBITDA US GAAP, €

Affimed. EBITDA US GAAP, changes, %

Affimed. EBITDA US GAAP, sum by quarters, €

Affimed (AFMD) EBITDA US GAAP (quarter values)

2023Q3 2024Q1 2023Q4 2024Q2 2024Q1   LTM ?
EBITDA, ? -23 565 000 -17 065 000 -20 825 000 -14 865 000 -17 065 000   -69 820 000
Changes by years, y/y, % +26% -25% -48%    
Changes by quarters, q/q, % -18% -28% +22% -29% +15%    

Affimed. EBITDA US GAAP, €

Affimed. EBITDA US GAAP, changes, y/y, %

Affimed. EBITDA US GAAP, changes, q/q, %